Brief: Allergy Therapeutics PLC Says FY Rev Expected To Be 16% Lower At £61.0 Million

Allergy Therapeutics

10/08/2023 07:42

Aug 10 (Reuters) - Allergy Therapeutics PLC  AGY.L :
    * ALLERGY THERAPEUTICS  - TRADING UPDATE FOR THE YEAR ENDED
30
JUNE 2023
    * ALLERGY THERAPEUTICS PLC - REVENUE FOR YEAR ENDED 30 JUNE
2023
IS EXPECTED TO BE 16% LOWER AT £61.0 MILLION
    * ALLERGY THERAPEUTICS PLC - FY UNDERLYING OPERATING LOSS
BEFORE
RESEARCH AND DEVELOPMENT COSTS, EXCEPTIONAL ITEMS EXPECTED TO BE
£13.3 MILLION
    * ALLERGY THERAPEUTICS PLC - SALES FOR FINANCIAL YEAR TO 30
JUNE
2024 EXPECTED TO BE SLIGHTLY LOWER THAN COMPARABLE PERIOD ENDED
30 JUNE 2023
    * ALLERGY THERAPEUTICS PLC - GROUP EXPECTS THAT ADDITIONAL
FUNDING
WILL BE REQUIRED FROM AROUND OCTOBER ONWARDS
    * ALLERGY THERAPEUTICS PLC - DISCUSSIONS ARE ONGOING WITH
CERTAIN
SHAREHOLDERS ON PROVIDING ADDITIONAL FUNDING

Source text for Eikon:  ID:nRSJ8575Ia 
Further company coverage:  AGY.L 

 ((Reuters.Briefs@thomsonreuters.com;))